Literature DB >> 20098426

Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.

Hongqing Du1, Melissa S Cline, Robert J Osborne, Daniel L Tuttle, Tyson A Clark, John Paul Donohue, Megan P Hall, Lily Shiue, Maurice S Swanson, Charles A Thornton, Manuel Ares.   

Abstract

The common form of myotonic dystrophy (DM1) is associated with the expression of expanded CTG DNA repeats as RNA (CUG(exp) RNA). To test whether CUG(exp) RNA creates a global splicing defect, we compared the skeletal muscle of two mouse models of DM1, one expressing a CTG(exp) transgene and another homozygous for a defective muscleblind 1 (Mbnl1) gene. Strong correlation in splicing changes for approximately 100 new Mbnl1-regulated exons indicates that loss of Mbnl1 explains >80% of the splicing pathology due to CUG(exp) RNA. In contrast, only about half of mRNA-level changes can be attributed to loss of Mbnl1, indicating that CUG(exp) RNA has Mbnl1-independent effects, particularly on mRNAs for extracellular matrix proteins. We propose that CUG(exp) RNA causes two separate effects: loss of Mbnl1 function (disrupting splicing) and loss of another function that disrupts extracellular matrix mRNA regulation, possibly mediated by Mbnl2. These findings reveal unanticipated similarities between DM1 and other muscular dystrophies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098426      PMCID: PMC2852634          DOI: 10.1038/nsmb.1720

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  60 in total

1.  Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1.

Authors:  John D Lueck; Codrin Lungu; Ami Mankodi; Robert J Osborne; Stephen L Welle; Robert T Dirksen; Charles A Thornton
Journal:  Am J Physiol Cell Physiol       Date:  2006-11-29       Impact factor: 4.249

2.  Muscle strength and body composition in adult women with Marfan syndrome.

Authors:  G Percheron; G Fayet; T Ningler; J-M Le Parc; S Denot-Ledunois; M Leroy; B Raffestin; G Jondeau
Journal:  Rheumatology (Oxford)       Date:  2007-02-28       Impact factor: 7.580

3.  Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy.

Authors:  James P Orengo; Pierre Chambon; Daniel Metzger; Dennis R Mosier; G Jackson Snipes; Thomas A Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-13       Impact factor: 11.205

4.  Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy.

Authors:  Thurman M Wheeler; John D Lueck; Maurice S Swanson; Robert T Dirksen; Charles A Thornton
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

5.  Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy.

Authors:  Minqi Hao; Kevan Akrami; Ke Wei; Carlos De Diego; Nam Che; Jeong-Hee Ku; James Tidball; Michael C Graves; Perry B Shieh; Fabian Chen
Journal:  Dev Dyn       Date:  2008-02       Impact factor: 3.780

6.  Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.

Authors:  Shin-Ichiro Hino; Shinichi Kondo; Hiroshi Sekiya; Atsushi Saito; Soshi Kanemoto; Tomohiko Murakami; Kazuyasu Chihara; Yuri Aoki; Masayuki Nakamori; Masanori P Takahashi; Kazunori Imaizumi
Journal:  Hum Mol Genet       Date:  2007-08-29       Impact factor: 6.150

7.  MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T.

Authors:  M Bryan Warf; J Andrew Berglund
Journal:  RNA       Date:  2007-10-17       Impact factor: 4.942

Review 8.  Expandable DNA repeats and human disease.

Authors:  Sergei M Mirkin
Journal:  Nature       Date:  2007-06-21       Impact factor: 49.962

9.  Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation.

Authors:  N Muge Kuyumcu-Martinez; Guey-Shin Wang; Thomas A Cooper
Journal:  Mol Cell       Date:  2007-10-12       Impact factor: 17.970

10.  Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs.

Authors:  Yuan Yuan; Sarah A Compton; Krzysztof Sobczak; Myrna G Stenberg; Charles A Thornton; Jack D Griffith; Maurice S Swanson
Journal:  Nucleic Acids Res       Date:  2007-08-15       Impact factor: 16.971

View more
  195 in total

1.  Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.

Authors:  Zhen Zhi Tang; Viktor Yarotskyy; Lan Wei; Krzysztof Sobczak; Masayuki Nakamori; Katy Eichinger; Richard T Moxley; Robert T Dirksen; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2011-12-02       Impact factor: 6.150

Review 2.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 3.  RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.

Authors:  Gloria V Echeverria; Thomas A Cooper
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

Review 4.  Vascular smooth muscle phenotypic diversity and function.

Authors:  Steven A Fisher
Journal:  Physiol Genomics       Date:  2010-08-24       Impact factor: 3.107

Review 5.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

6.  The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus.

Authors:  Zhihong Zhou; Jinsong Qiu; Wen Liu; Yu Zhou; Ryan M Plocinik; Hairi Li; Qidong Hu; Gourisanker Ghosh; Joseph A Adams; Michael G Rosenfeld; Xiang-Dong Fu
Journal:  Mol Cell       Date:  2012-06-21       Impact factor: 17.970

7.  Autoregulated splicing of muscleblind-like 1 (MBNL1) Pre-mRNA.

Authors:  Devika P Gates; Leslie A Coonrod; J Andrew Berglund
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

8.  Reducing levels of toxic RNA with small molecules.

Authors:  Leslie A Coonrod; Masayuki Nakamori; Wenli Wang; Samuel Carrell; Cameron L Hilton; Micah J Bodner; Ruth B Siboni; Aaron G Docter; Michael M Haley; Charles A Thornton; J Andrew Berglund
Journal:  ACS Chem Biol       Date:  2013-09-27       Impact factor: 5.100

Review 9.  Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Authors:  Vittoria Pagliarini; Piergiorgio La Rosa; Claudio Sette
Journal:  Hum Genet       Date:  2017-04-22       Impact factor: 4.132

Review 10.  Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.

Authors:  Zhihua Gao; Thomas A Cooper
Journal:  Hum Gene Ther       Date:  2013-01-30       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.